STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Dec. 31, 2015

STOCKHOLDERS' EQUITY [Abstract]

Schedule of Stock Option Activity

	Six months ended December 31, 2015 (Unaudited)
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options outstanding at beginning of period		1,836,900		$	3.72
Options exercised		(25,000	)	$	0.62
Options outstanding at end of the period		1,811,900		$	3.77		1.62	$	451
Options exercisable at the end of the period		1,811,900		$	3.77		1.62	$	451
Options vested		1,811,900		$	3.77		1.62	$	451

Schedule of Stock Option and Warrant Activity

	Six months ended December 31, 2015 (Unaudited)
	Number		Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options and warrants outstanding at end of the period		228,000	$	5.73		2.36	$	147
Options and warrants exercisable at the end of the period		227,250	$	5.75		2.34	$	145
Options and warrants vested and expected to vest		228,000	$	5.73		2.36	$	147

Options and warrants [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses

	Six months ended December 31,				Three months ended December 31,
	2015		2014		2015		2014
	(Unaudited)				(Unaudited)
Research and development expenses	$	1	$	1	$	-	$	-

Restricted stock units [Member]

Stockholders Equity Note [Line Items]

Schedule of Unvested Restricted Stock Units

	Number
Unvested at the beginning of period		1,732,383
Granted		14,270
Forfeited		(45,477	)
Vested		(776,727	)
Unvested at the end of the period		924,449
Expected to vest after  December 31, 2015		893,867

Schedule of Stock-based Compensation Expenses

	Six months ended December 31,				Three months ended December 31,
	2015		2014		2015		2014
	(Unaudited)				(Unaudited)
Research and development expenses	$	483	$	495	$	163	$	162
General and administrative expenses		1,020		1,143		446		441
	$	1,503	$	1,638	$	609	$	603

Consultant restricted stock units [Member]

Stockholders Equity Note [Line Items]

Schedule of Unvested Restricted Stock Units

	Number
Unvested at the beginning of period		28,385
Granted		135,387
Vested		(162,772	)
Unvested at the end of the period		1,000

Schedule of Stock-based Compensation Expenses

	Six months ended December 31,				Three months ended December 31,
	2015		2014		2015		2014
	(Unaudited)				(Unaudited)
Research and development expenses	$	20	$	77	$	10	$	57
General and administrative expenses		48		38		45		34
	$	68	$	115	$	55	$	91